Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Year: 1996
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: J D Bitran, B Samuels, L Klein, S Hanauer, L Johnson, J Martinec, E Harris, J Kempler, W White
Institutions: Advocate Lutheran General Hospital, University of Chicago
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2401422749
